Behind the Science - Season 10

As nontraditional pharmacy career paths grow, pharmacy technicians have begun to find space to grow as well. On this episode, experts highlight their various roles in the pharmacy, including pharmacy regulatory specialists, a drug diversion analyst, a pharmacy education support specialist, and a pharmacy distribution specialist.

During the recent Digestive Disease Week (DDW) meeting in Chicago from May 6-9, AI was a major topic of discussion. During the meeting Drs. Shaukat and Lee shared insight into how AI is being utilized specifically for colorectal cancer screenings to better detect polyps and forecast risk.

Breast radiologists shared their thoughts on a recently issued final rule from the Food and Drug Administration requiring national breast density notification on mammography reports starting on September 10, 2024. They also discussed next steps for improving breast density awareness among primary care physicians and the potential for expanding supplemental imaging coverage for women with dense breasts via the Find it Early Act legislation, which was reintroduced in Congress on May 8, 2023.

In companies and research centers worldwide, advances in technologies and approaches to therapies in development are changing traditional healthcare approaches. Artificial intelligence, data science, smart speakers, natural language processing, remote patient monitoring, digital therapeutics and more is changing the way how patients will be treated, as well as when and where. We recently asked experts, “What technologies are changing the future of patient healthcare?”

The editors at CancerNetwork® met with a diverse group of clinicians and thought leaders in the kidney cancer space to discuss recent developments, the role of integrative oncology, persistent unmet needs, and the most promising developments on the horizon in this treatment landscape.

A showcase of the latest advances in neuromuscular medicine, the annual Muscular Dystrophy Association (MDA) Clinical and Scientific Conference represents a premier event on the calendar for neuromuscular researchers and clinicians. At the meeting, NeurologyLive’s editorial team asked leading experts questions such as important aspects of care for patients and what other clinicians should be aware of based on talk presentations given at this year’s meeting.

Experts discuss recent research presented at ASH 2022 regarding Bruton’s tyrosine kinase (BTK) inhibitors and JAK inhibitors like ibrutinib, zanubrutinib, and ruxolitinib, for the treatment of patients with a variety of hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and more.

Clinicians and key stakeholders give commentary about the challenges of treating individuals with various strains of hepatitis as well as the new hope associated with federal and state levels programs looking to get more people into care.

Thought leaders from across the ophthalmology community share their perspectives on the most pressing issues facing the profession today. The areas of concern range from physician burnout to patient volume to costs, and more.